Novabay Pharmaceuticals Inc

Novabay Pharmaceuticals Inc

NBY - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$321.37M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Novabay Pharmaceuticals IncNovabay Pharmaceuticals Inc0.1409.21%421%-1.5-
$1.23

Current Fair Value

16% downside

Overvalued by 16% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$321.37 Million
Enterprise Value$314.40 Million
Annual dividend$4.00
Dividend yield409.21%
Earnings per Share$-3.8
Beta0.16
Outstanding Shares218,632,000

Return

Return on Equity420.53%ROE
Return on Assets419.64%
Return on Invested Capital28.47%

Valuation & Multiples

P/E Ratio0.06P/E Ratio
PEG0PEG
Price to Sales-1.47Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-603.45
Enterprise Value to EBIT8.68
Enterprise Value to Net Income0
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
April 1, 2026
EPS Estimate
$-1.00
Consensus analyst estimate
Revenue Estimate
$3.60 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %6.30%▲ 1.61%
Total Invested$2.44M▼ 92.90%
Investors Holding24▼ 2.00%

About Novabay Pharmaceuticals Inc

4 employees
CEO: Justin Hall

Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the...

Novabay Pharmaceuticals Insider Information FAQ

Stockcircle tracks 2 top investors with a current 13F position in Novabay Pharmaceuticals. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.